Arcadia Biosciences, Inc.
RKDA
$3.40
-$0.0813-2.34%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.83M | -6.78M | -7.02M | -13.98M | -15.37M |
| Total Depreciation and Amortization | 816.00K | 926.00K | 961.00K | 984.00K | 1.05M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.33M | -4.48M | -4.95M | 1.25M | 1.85M |
| Change in Net Operating Assets | -2.18M | -2.33M | -3.99M | -3.51M | -1.03M |
| Cash from Operations | -11.52M | -12.66M | -15.00M | -15.25M | -13.51M |
| Capital Expenditure | -16.00K | -16.00K | -18.00K | -5.00K | -31.00K |
| Sale of Property, Plant, and Equipment | 415.00K | 240.00K | 102.00K | 115.00K | 65.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.48M | 4.48M | -4.74M | -4.45M | -4.15M |
| Cash from Investing | 4.88M | 4.70M | -4.66M | -4.34M | -4.12M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.00K | 12.00K | 12.00K | 6.01M | 6.01M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | -497.00K | -497.00K |
| Cash from Financing | 9.00K | 12.00K | 12.00K | 5.51M | 5.51M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.64M | -7.94M | -19.64M | -14.09M | -12.11M |
